317 related articles for article (PubMed ID: 14729984)
1. Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.
Guo F; Zheng Y
Mol Cell Biol; 2004 Feb; 24(3):1426-38. PubMed ID: 14729984
[TBL] [Abstract][Full Text] [Related]
2. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
Guo F; Zheng Y
Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
[TBL] [Abstract][Full Text] [Related]
3. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.
Guo F; Gao Y; Wang L; Zheng Y
J Biol Chem; 2003 Apr; 278(16):14414-9. PubMed ID: 12578823
[TBL] [Abstract][Full Text] [Related]
4. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
5. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of Rac and Cdc42 on p38 kinase activity and cell cycle progression of nonadherent primary mouse fibroblasts.
Philips A; Roux P; Coulon V; Bellanger JM; Vié A; Vignais ML; Blanchard JM
J Biol Chem; 2000 Feb; 275(8):5911-7. PubMed ID: 10681583
[TBL] [Abstract][Full Text] [Related]
7. Developmental expression of three small GTPases in the mouse eye.
Mitchell DC; Bryan BA; Liu JP; Liu WB; Zhang L; Qu J; Zhou X; Liu M; Li DW
Mol Vis; 2007 Jul; 13():1144-53. PubMed ID: 17653061
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
Groth A; Weber JD; Willumsen BM; Sherr CJ; Roussel MF
J Biol Chem; 2000 Sep; 275(35):27473-80. PubMed ID: 10842176
[TBL] [Abstract][Full Text] [Related]
9. Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42.
Weernink PA; Meletiadis K; Hommeltenberg S; Hinz M; Ishihara H; Schmidt M; Jakobs KH
J Biol Chem; 2004 Feb; 279(9):7840-9. PubMed ID: 14681219
[TBL] [Abstract][Full Text] [Related]
10. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
[TBL] [Abstract][Full Text] [Related]
11. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
12. p19ARF-induced p53-independent apoptosis largely occurs through BAX.
Suzuki H; Kurita M; Mizumoto K; Nishimoto I; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2003 Dec; 312(4):1273-7. PubMed ID: 14652011
[TBL] [Abstract][Full Text] [Related]
13. Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.
Chao HH; Buchmann AM; DeCaprio JA
Mol Cell Biol; 2000 Oct; 20(20):7624-33. PubMed ID: 11003658
[TBL] [Abstract][Full Text] [Related]
14. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
[TBL] [Abstract][Full Text] [Related]
15. Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.
Matsuoka M; Kurita M; Sudo H; Mizumoto K; Nishimoto I; Ogata E
Biochem Biophys Res Commun; 2003 Feb; 301(4):1000-10. PubMed ID: 12589812
[TBL] [Abstract][Full Text] [Related]
16. ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.
Benitah SA; Valerón PF; Lacal JC
Mol Biol Cell; 2003 Jul; 14(7):3041-54. PubMed ID: 12857884
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
18. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
19. Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes.
Teramoto H; Malek RL; Behbahani B; Castellone MD; Lee NH; Gutkind JS
Oncogene; 2003 May; 22(17):2689-97. PubMed ID: 12730683
[TBL] [Abstract][Full Text] [Related]
20. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
